Michael Burger

Michael Burger

Auto-generated profile, based on publicly available information

Michael Burger

ETH Zurich, Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Vladimir-Prelog-Weg 3, 8093 Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2023 in Advanced Drug Delivery Reviews
Verified
Journal Article
Open access
AKAlexander Klipp
Alexander Klipp
MBMichael Burger
Michael Burger
JLJean-Christophe Leroux
Jean-Christophe Leroux
RNA therapeutics offer great potential to transform the biomedical landscape, encompassing the treatment of hereditary conditions and the development of better vaccines. However, the delivery of RNAs into the cell is hampered, among others, by poor endosomal escape. This major hurdle is often tackled using special lipids, polymers, or protein-based delivery vectors. In this review, we will focus on the most prominent peptide- and protein-based endosomal escape strategies with focus on RNA drugs. We discuss cell penetrating peptides, which are still incorporated into novel transfection systems today to promote endosomal escape. However, direct evidence for enhanced endosomal escape by the action of such peptides is missing and their transfection efficiency, even in permissive cell culture conditions, is rather low. Endosomal escape by the help of pore forming proteins or phospholipases, on the other hand, allowed to generate more efficient transfection systems. These are, however, often hampered by considerable toxicity and immunogenicity. We conclude that the perfect enhancer of endosomal escape has yet to be devised. To increase the chances of success, any new transfection system should be tested under relevant conditions and guided by assays that allow direct quantification of endosomal escape.

1 October 2023 in Molecular Biology of the Cell
Verified
Journal Article
Open access
LSLaura Schenkel
Laura Schenkel
XWXuan Wang
Xuan Wang
NLNhung Le
Nhung Le
MBMichael Burger
Michael Burger
RKRuth Kroschewski
Ruth Kroschewski
Mammalian cells express transfected plasmid DNA transiently, but the underlying mechanisms are not well known. Plasmid DNA was found to be captured in the cytoplasmic, (ER)Endoplasmic reticulum-enwrapped exclusome, which clusters both endogenous and exogenous extrachromosomal DNA. Exclusome-envelope formation corresponded to early but not late steps of nuclear-envelope formation. This work suggests that a cell-autonomous genome protection system recognizes, collects, and maintains extrachromosomal DNA in somatic mammalian cells.

25 March 2024 in Drug Delivery and Translational Research
Verified
Journal Article
Open access
PDF file
CGChristina Greitens
Christina Greitens
JLJean-Christophe Leroux
Jean-Christophe Leroux
MBMichael Burger
Michael Burger
In the development of non-viral gene delivery vectors, it is essential to reliably localize and quantify transfected DNA inside the cell. To track DNA, fluorescence microscopy methods are commonly applied. These mostly rely on fluorescently labeled DNA, DNA binding proteins fused to a fluorescent protein, or fluorescence in situ hybridization (FISH). In addition, co-stainings are often used to determine the colocalization of the DNA in specific cellular compartments, such as the endolysosomes or the nucleus. We provide an overview of these DNA tracking methods, advice on how they should be combined, and indicate which co-stainings or additional methods are required to draw precise conclusions from a DNA tracking experiment. Some emphasis is given to the localization of exogenous DNA inside the nucleus, which is the last step of DNA delivery. We argue that suitable tools which allow for the nuclear detection of faint signals are still missing, hampering the rational development of more efficient non-viral transfection systems. Graphical abstract The intracellular visualization of exogenous DNA in fluorescence microscopy. Created with BioRender.com.

15 April 2024 in Bioconjugate Chemistry
Verified
Journal Article
Open access
DSDavid Scherer
David Scherer
MBMichael Burger
Michael Burger
JLJean-Christophe Leroux
Jean-Christophe Leroux

18 July 2024 in Journal of Controlled Release
Verified
Journal Article
Open access
SHSteffen Honrath
Steffen Honrath
DSDavid Scherer
David Scherer
MBMichael Burger
Michael Burger
JLJean-Christophe Leroux
Jean-Christophe Leroux
In an earlier investigation, our group introduced the TFAMoplex, a transfection agent based on the mitochondrial transcription factor A (TFAM) protein, which complexes DNA into nanoparticles. The original TFAMoplex further contained a bacterial phospholipase to achieve endosomal escape, and the vaccinia-related kinase 1 (VRK1), which significantly boosted the transfection efficiency of the system by an unknown mechanism. This study aims at replacing VRK1 within the TFAMoplex with dynein light chain proteins, specifically RP3, to directly tether the complexes to the dynein motor complex for enhanced cytosolic transport. To confirm the interaction between the dynein complex and the resulting fusion protein, we examined the binding kinetics of TFAM-RP3 to the dynein intermediate chains 1 and 2. Furthermore, we established a proteomics-based assay to compare cytosolic protein interactions of different TFAMoplex variants, including the RP3-modified version and the original VRK1-containing system. In the group of the VRK1-containing TFAMoplex, significant shifts of protein interactors were observed, especially for nucleolar proteins. Leveraging this knowledge, we incorporated one of these nuclear proteins, leucine-rich repeat-containing protein 59 (LRRC59), into the TFAMoplex, resulting in a significant improvement of transfection properties compared to the RP3-modified system and comparable levels versus the original, VRK1-containing version. This study not only advances our comprehension of the TFAMoplex system but also offers broader insights into the potential of protein engineering for designing effective gene delivery systems.

25 February 2025 in Advanced Science
Verified
Journal Article
Open access
AKAlexander Klipp
Alexander Klipp
CGChristina Greitens
Christina Greitens
DSDavid Scherer
David Scherer
AEAlexander Elsener
Alexander Elsener
JLJean‐Christophe Leroux
Jean‐Christophe Leroux
MBMichael Burger
Michael Burger
Gene delivery systems must overcome multiple barriers, with endosomal escape representing a prominent obstacle. We have previously shown that a bacterial phospholipase C (PLC) enabled endosomal escape of a non‐viral protein‐based DNA delivery system termed TFAMoplex. Building upon this, this work introduces a calcium‐responsive system designed to enhance endosomal escape through non‐covalent capturing of PLC to the TFAMoplex followed by its release within endosomes and nanobody‐mediated targeting to the endosomal membrane. This approach leads to improved TFAMoplexes enabling transfection of HeLa cells in full serum with a half maximal effective concentration (EC50) of less than 200 ng DNA per mL serum, using only 5 nM PLC. Particularly, the modular capture, release and targeting system could potentially be adapted to other delivery agents previously constrained by poor endosomal escape. These findings present a promising strategy to achieve efficient endosomal escape, offering prospects for improved delivery of macromolecules, in particular nucleic acids.